![]() ![]() We will continue to vigorously protect our innovative products, solutions and intellectual property,” said Chris Barry, Covidien’s advanced surgical technologies president, in prepared remarks. We are pleased that the federal court recognized our innovation in ultrasonic surgical devices, finding our patents both valid and infringed by Ethicon Endo-Surgery. Design change leads to premature lockout of Ethicon Endo-Surgery Proximate reloadable linear cutters. The Company offers trocars, insufflation needles, single site laparoscopy. “As a global healthcare market leader, Covidien invests significant resources into creating and developing medical innovations. designs, manufactures, and distributes medical devices. The royalty damages were $140.1 million and the prejudgment interest amounted to $36.4 million, according to court documents. "Tyco is entitled to 8% royalty damages and 3.25% prejudgment interest for damages in the total amount of $176,500,800.00."Īrterton decided that the infringing sales by Ethicon from April 1, 2004, to March 31, 2012, amounted to $1.75 billion, using that figure to calculate the damages. "he evidence presented at trial shows that Tyco’s and Ethicon’s advanced energy products directly competed with each other," Arterton wrote. Ethicon Code: TG160-6, TG160-6, 1/2 Circle - 1/2 Circle, 5.5mm, 5.5mm 11-0 6in BLACK 12 TG160-6, TG160-6 -NA D7811: 10-0 6in BLACK 12 TG160-6, TG160-6 -NA 7757G: 10-0 12in BLACK 12 TG160-6, TG160-6 -NA 7756G: CUTTING EDGE ULTIMA REVERSE, CUTTING EDGE ULTIMA REVERSE: Suture Size: Length: Color: QTY/BX: Needle Name: Special: Pledget Size: Ethicon. Ethicon EndoSurgery (EES) is a division of Johnson & Johnson Medical that markets advanced medical devices for conventional open surgeries and minimally. Surgical Corp., with products including its Autosonix and LCS ultrasonic scalpels (Covidien’s competing products include its Harmonic Shears, according to the court documents).Ĭovidien "proved infringement of all asserted claims of the patents in suit" but failed to prove willful infringement (closing the door on the possibility of triple damages) and isn’t entitled to lost profits damages or a preliminary injunction, Arterton wrote, according to the documents. Judge Janet Bond Arterton ruled that Ethicon Endo-Surgery infringed 6 claims in 3 patents held by Covidien’s corporate predecessors, Tyco Healthcare and U.S. ![]() UPDATED March 29, 2013, with comment from Covidien.Ĭovidien (NYSE: COV) won a nearly $177 million victory yesterday over Johnson & Johnson‘s (NYSE: JNJ) Ethicon Endo-Surgery subsidiary in a patent war over ultrasonic scalpel technology. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |